title: Quantification of low levels of human immunodeficiency virus (HIV) type 1 RNA in P24 antigen-negative, asymptomatic, HIV-positive patients by PCR.
abstract: A nested PCR was used to quantify small numbers of human immunodeficiency virus (HIV) type 1 (HIV-1) RNA particles in the serum specimens of 26 p24 antigen-negative, asymptomatic, HIV-positive patients undergoing antiretroviral therapy. Fifteen patients received zidovudine (ZDV) and alpha interferon, and 11 patients received ZDV monotherapy. After PCR, the amounts of RNA were quantified by comparing the endpoint dilutions of serum samples with a standard curve with known amounts of viral particles. Before the beginning of the antiviral therapy, HIV-1 RNA was detected in 92% of the patients. After treatment, a fall in the number of viral particles was detected in patients receiving combination therapy (mean titers +/- standard errors of the means, 3,617 +/- 756 pretherapy versus 1,800 +/- 845 posttherapy; P < 0.05) and in patients receiving monotherapy (3,763 +/- 642 pretherapy versus 1,353 +/- 394 posttherapy; P < 0.05). Our results indicate that PCR with nested primers may be useful for assessing the changes in viremia in HIV-positive patients with low viral load undergoing antiviral therapy.
authors.forename: M A
authors.initials: MA
authors.lastname: Muñoz-Fernández
authors.forename: J
authors.initials: J
authors.lastname: Navarro
authors.forename: M G
authors.initials: MG
authors.lastname: Montes
authors.forename: J
authors.initials: J
authors.lastname: Cosín
authors.forename: J M
authors.initials: JM
authors.lastname: Zabay
authors.forename: E
authors.initials: E
authors.lastname: Fernández-Cruz
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D016655:HIV Core Protein p24 / Q000097:blood; D006679:HIV Seropositivity / Q000188:drug therapy / Q000628:therapy / Q000821:virology*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D016133:Polymerase Chain Reaction / Q000379:methods* / Q000706:statistics & numerical data; D012367:RNA, Viral / Q000097:blood* / Q000235:genetics; D012680:Sensitivity and Specificity; D014766:Viremia / Q000188:drug therapy / Q000628:therapy / Q000821:virology; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D016655:HIV Core Protein p24; D016898:Interferon-alpha; D012367:RNA, Viral; D015215:Zidovudine